ICD-10 Code L62: Nail disorders in diseases classified elsewhere

Key Takeaways

ICD-10 Code L62 (Nail disorders in diseases classified elsewhere) is a billable, specific ICD-10-CM code for nail changes caused by a systemic or dermatologic underlying condition

L62 is a manifestation code: the underlying etiology must always be sequenced first, per the ICD-10-CM etiology/manifestation convention

The ICD-10-CM tabular list names pachydermoperiostosis (M89.4-) as the code-first example; coding L62 without any underlying etiology code is a common audit risk

Pabau’s claims management software helps dermatology and podiatry practices apply correct sequencing and reduce L62-related claim denials

ICD-10 code L62 (Nail disorders in diseases classified elsewhere) is a billable, specific ICD-10-CM manifestation code for nail changes caused by a disease coded in another chapter. It carries a mandatory “code first” instruction: the underlying disease — such as pachydermoperiostosis (M89.4-) — must be sequenced first, with L62 reported second.

This reference covers ICD-10 Code L62 definition and billable status, sequencing rules under the etiology/manifestation convention, underlying conditions that trigger its use, related nail disorder codes, and documentation requirements for dermatology, podiatry, and general practice settings.

ICD-10 Code L62: Definition and clinical description

ICD-10 Code L62 describes nail disorders that occur as a direct manifestation of a disease classified in another chapter of ICD-10-CM. The full official descriptor is “Nail disorders in diseases classified elsewhere.”

The code sits within the L60-L75 range, which covers disorders of skin appendages. Nails, hair follicles, and sweat glands all fall under this block. L62 specifically represents nail involvement secondary to a systemic or dermatologic process, not a primary nail condition.

• Code: L62
• Full descriptor: Nail disorders in diseases classified elsewhere
• Chapter: L00-L99 (Diseases of the skin and subcutaneous tissue)
• Block: L60-L75 (Disorders of skin appendages)
• Billable/Specific: Yes, confirmed by the CDC/NCHS ICD-10-CM web tool
• Valid for reimbursement: Dates of service on or after October 1, 2015

The L62 tabular entry carries no inclusion-term synonyms of its own; instead it prints a “code first” instruction naming pachydermoperiostosis (M89.4-) as the underlying disease example. Other systemic or dermatologic diseases that produce documented nail changes may also be reported with L62, but only when the provider’s note explicitly links the nail finding to the active underlying condition.

Billable status and reimbursement guidance for L62

L62 is a billable, specific ICD-10-CM code. Payers accept it for reimbursement claims when it is sequenced correctly with its underlying etiology. “Specific” in ICD-10-CM terms means no further subdivision is required: L62 is already the most granular level available for this manifestation category.

The code became valid for all payers following the mandatory ICD-10-CM transition on October 1, 2015, per CMS guidance on ICD-10-CM codes. Claims submitted with dates of service prior to that date should use the corresponding ICD-9-CM codes through legacy systems.

Two reimbursement cautions apply. First, L62 cannot stand alone as the only diagnosis on a claim: the “code first” note means an etiology code must appear before it, or most payers will reject the claim. Second, payer-specific medical policies may impose additional documentation requirements beyond ICD-10-CM sequencing. Practices should verify LCD (Local Coverage Determination) policies with their MAC before submitting.

Pabau’s claims management software flags incomplete diagnosis code pairs at the point of billing, reducing L62-related denials before they reach the payer.

ICD-10-CM etiology/manifestation convention and sequencing rules

The most consequential coding rule for L62 is the etiology/manifestation convention. Under AAPC’s ICD-10-CM coding guidelines, certain conditions have both an underlying etiology and body-system manifestations caused by that etiology. ICD-10-CM requires two codes: the etiology is sequenced first; the manifestation (L62) follows.

This is governed by a “code first” note printed in the tabular list immediately above L62. Coders relying on ICD-10-CM etiology/manifestation principles will recognize this as the same convention applied across dozens of manifestation codes throughout the classification. The instruction is not optional: sequencing the manifestation first will trigger an NCCI (National Correct Coding Initiative) edit or payer denial in most claim auditing systems.

Step-by-step sequencing walkthrough

1. Identify and code the underlying condition first. This is the disease causing the nail change (e.g., psoriasis, lichen planus, alopecia areata). The etiology code appears in the primary diagnosis field.
2. Assign L62 as an additional diagnosis code. L62 captures the nail manifestation and goes in a secondary diagnosis field on the claim.
3. Confirm the clinical link is documented. The provider’s note must state that the nail disorder is attributable to the listed underlying condition. Vague documentation (“nail changes, query etiology”) will not support the code pair.
4. Check payer-specific LCD policies. Some Medicare Administrative Contractors have coverage determinations that add specificity requirements for dermatologic manifestation codes.

Getting the order reversed (L62 first, etiology second) is the single most common billing error associated with this code. Several clearinghouse edits will catch it, but practices that self-submit claims or use older billing software may not receive the rejection in time to rework the claim within the payer’s timely filing window.

Underlying conditions reported with ICD-10 Code L62

The ICD-10-CM tabular list names pachydermoperiostosis (M89.4-) as the code-first example for L62. Beyond that named example, the etiology/manifestation convention extends to other systemic or dermatologic diseases whose nail involvement is documented and clinically linked to the underlying condition. The conditions below are reported with L62 only when the provider’s note ties the nail finding to the active underlying disease — they are not paired automatically.

The pattern is consistent across these conditions: the underlying systemic or dermatologic disease — for example, psoriasis (L40.0) — drives the primary code, and L62 captures the nail-specific findings when they are documented. Coders should not use L62 for fungal nail infections (B35.1), traumatic nail disorders (S60.x), or primary structural nail disorders documented without an underlying systemic cause, as these have their own specific codes in the L60 range or elsewhere.

ICD-10 Code L62 compared to L60.x nail disorder codes

The L60 block and L62 serve different clinical purposes and represent a common point of confusion in dermatology and podiatry coding. Understanding where each code applies prevents unbundling errors and denials.

L60.x codes describe primary nail conditions where no underlying systemic disease is driving the nail change. L62, by contrast, is reserved for nail involvement that is a manifestation of a separately coded condition. The AAPC’s ICD-10-CM coding guidelines and the WHO ICD-10 browser both place these codes in distinct subcategories for this reason.

The critical distinction: if a patient presents with onycholysis and has documented psoriasis that is causing it, L40.x should appear first, followed by L62 (not L60.1). Using L60.1 when a systemic etiology exists understates the clinical complexity of the encounter and may limit reimbursement for the additional evaluation involved. For more on related ICD-10 diagnostic codes and how the etiology/manifestation rule applies across the classification, the principle is consistent throughout ICD-10-CM.

Reduce L62 claim denials with Pabau

Pabau's claims management tools flag missing etiology codes and incomplete diagnosis pairs before claims leave the practice, helping dermatology and podiatry teams submit cleaner batches from day one.

Book a demo

Documentation requirements for L62

Payers auditing L62 claims look for one thing above all: explicit documentation that the nail finding is causally related to the listed underlying condition. A chart note that records both psoriasis and nail pitting but does not connect them will not support the code pair on appeal.

Practices using digital intake forms can build dermatologic history capture into the pre-visit workflow, ensuring that systemic conditions like psoriasis or lichen planus are flagged before the clinician enters the exam room. This reduces the documentation gap that produces L62 denials. For structured clinical documentation, the core elements payers expect are:

• Explicit causal statement: The clinical note must state that the nail disorder is a manifestation of or attributable to the named underlying condition (e.g., “nail pitting consistent with psoriatic nail involvement”).
• Current active status of the etiology: The underlying condition (psoriasis, lichen planus, etc.) must be documented as currently active, not historical only.
• Examination findings: Objective nail findings (pitting, ridging, onycholysis, subungual hyperkeratosis) should be listed with laterality and affected digits where clinically relevant.
• Treatment plan tied to both diagnoses: Where treatment addresses the nail manifestation specifically (nail debridement, topical therapy), the plan should reference both the etiology and the L62 manifestation to support medical necessity.

Pabau’s patient record management system supports structured clinical note templates that prompt clinicians to document causal relationships, reducing the risk of incomplete records that coders cannot safely code. Keeping clinical documentation workflows standardized across providers also improves consistency in multi-clinician settings.

Coding conventions and audit risks for L62

Beyond sequencing, three ICD-10-CM coding conventions directly affect how L62 should be applied in practice, and where audit risk concentrates.

Type 1 Excludes note

The L62 entry does not carry a Type 1 Excludes note for most of the common underlying conditions listed above, meaning the code pair (etiology + L62) is the intended coding approach. However, coders should always verify against the current year’s tabular list, as excludes notes can be updated in annual ICD-10-CM releases. The CDC/NCHS ICD-10-CM web tool provides year-specific tabular lists that reflect current excludes instructions.

Principal vs. additional diagnosis

L62 is never the principal diagnosis. The etiology is always principal. In inpatient settings, UHDDS definitions require that the principal diagnosis be the condition established after study to be chiefly responsible for the admission.

In outpatient dermatology and podiatry, the primary diagnosis on the claim form corresponds to the main reason for the visit; if nail involvement is the presenting complaint but psoriasis is the underlying driver, coding conventions still require the psoriasis code first. Practices relying on compliance management tools can automate alerts when a manifestation code appears in the primary position.

Common audit triggers

• L62 submitted without an etiology code: The most common error. Most claim scrubbers will flag this, but not all.
• Etiology code placed in secondary position: Reversed sequencing triggers NCCI edits and payer-level audits.
• Using L60.9 or L60.8 when a systemic etiology is documented: Under-coding reduces reimbursement and misrepresents clinical complexity.
• Lack of causal documentation: Payers conducting post-payment audits will recoup payments where the chart does not support the code pair relationship.

Practices running internal audits on ICD-10 documentation across other diagnostic categories can apply the same audit framework to L62 claims: pull a sample of claims with L62 in any position, verify that an etiology code precedes it on each, and spot-check that the clinical note contains a causal statement. A monthly audit sample of 10-15 L62 claims will catch systematic sequencing errors before they accumulate into significant payer recoupment exposure.

Conclusion

ICD-10 Code L62 is straightforward once the etiology/manifestation rule is internalized: nail disorders caused by an underlying systemic or dermatologic condition require the etiology code first, L62 second, with clinical documentation explicitly connecting the two. The most common errors (reversed sequencing, L62 alone, or a weaker L60.x code when a systemic driver is documented) are preventable with front-end coding controls and standardized note templates.

For skin clinic software that supports structured dermatology documentation, diagnosis code pairing at the point of care, and claims scrubbing before submission, book a demo with Pabau to see how the workflow fits your practice.

Continue your research

Need structured clinical note templates for dermatology? Skin assessment tools guide covers evidence-based frameworks for documenting skin and nail findings systematically.

Managing a multi-provider dermatology or podiatry practice? Dermatology EMR software overview explains how Pabau supports specialty-specific documentation and coding workflows.

Want to reduce claim denials across your diagnostic code set? Claims management software walks through how automated code pairing checks work at the point of billing.

Frequently Asked Questions